Drugmaker seeks FDA approval for over-the-counter birth control
For the first time, a pharmaceutical company has asked for permission to sell a birth control pill over the counter in the United States.
Pharmaceutical
Articles
Inotiv facing shareholder lawsuit over stock drop
The West Lafayette-based pharmaceutical testing company has seen its stock price soar—and later plunge—following its announcement last fall that it planned to acquire Indianapolis-based Envigo RMS LLC, which breeds and sells animals used in lab testing.
Q&A with Cathy Langham about growing cold-storage demand
Indianapolis-based Langham Logistics is set to open a 150,000-square-foot warehouse in Whitestown to serve pharmaceutical and biotech companies—and their suppliers—who need cold storage, meaning anything from chilled space to ultra-low-temperature freezers.
FDA authorizes first COVID-19 shots for infants, preschoolers
The FDA also authorized Moderna’s vaccine for school-aged children and teens. Pfizer’s shots had been the only option for those ages.
FDA advisers endorse first COVID-19 shots for children under 5
An advisory panel for the Food and Drug Administration gave a thumbs-up Wednesday to vaccines from Moderna and Pfizer for children under 5. It’s the only age group not yet eligible for vaccination against the coronavirus.
Lilly whistleblower sues drugmaker, alleging retaliation
A top human resources officer at Eli Lilly and Co.’s factory in New Jersey claims the drugmaker fired her in retaliation for investigating employee complaints about drug manufacturing problems and for refusing to drop the matter.
Small cancer drug trial sees tumors disappear in 100% of patients
Researchers in the field of colorectal cancer are hailing the study, published Sunday in the New England Journal of Medicine, as a groundbreaking development that could lead to new treatments for other cancers as well.
AG: All Indiana communities now participating in $507M opioid settlement
The Attorney General’s office reported all 648 political subdivisions in Indiana have joined the settlement, which is part of a roughly $26 billion payout across 46 states.
FDA advisers back Novavax COVID-19 shots as new option
Novavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company.
Pharma company plans $220M expansion in Indiana, 80 new jobs
Germany-based Evonik announced Thursday that it will expand its pharmaceutical production facility in Lafayette. The plant will build produce lipids for mRNA-based therapies in the United States.
Lilly to anchor state’s new innovation district with $2.1B in manufacturing facilities
The Indianapolis-based drugmaker said Wednesday the project in Boone County will create up to 500 jobs in central Indiana, along with up to 1,500 temporary construction jobs.
FDA approves Lilly diabetes drug that helps patients lose weight
The drug has been closely watched by medical professionals and is viewed by financial analysts as a possible blockbuster, with potential annual sales in the billions of dollars.
Lilly’s new weight-loss drug is a ‘double wow’ and likely blockbuster
The pharmaceutical giant is turning heads with an experimental medicine it claims can help obese patients shed nearly a quarter of their body weight and manage diabetes.
Life sciences experts say Indiana needs to push collaborations to compete with other states
A panel of Indiana life science experts on Friday said the state could become more competitive for large investments and jobs if it doubled down on the kind of collaborations and partnerships that other states have used to their advantage.
Lilly profit soars 40% in first quarter
Eli Lilly and Co. posted profit of $1.9 billion in the first quarter, up 40%, on higher sales of COVID-19 antibodies and other key products for diabetes, cancer and arthritis.
Moderna seeks to be first with COVID shots for littlest children
Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.
Lilly says experimental drug helped patients lose up to 22% of body weight
The drug, called tirzepatide, has been closely watched by medical professionals and is viewed by financial analysts as possible blockbuster, with potential annual sales in the billions of dollars.
Administration expanding availability of COVID antiviral pill
Paxlovid, when administered within five days of symptoms appearing, has been proven to bring about a 90% reduction in hospitalizations and deaths among patients most likely to get severe disease.
COVID shots still work, but researchers hunting new improvements
COVID-19 vaccinations are at a critical juncture as companies test whether new approaches like combination shots or nasal drops can keep up with a mutating coronavirus—even though it’s not clear if changes are needed.
Indianapolis-based Telix rolls out method for detecting cancer
The imaging agent is the six-year-old company’s first commercial launch, following millions of dollars’ worth of research and clinical tests. It was approved by the U.S. Food and Drug Administration in December.